▶ 調査レポート

水痘弱毒生ワクチンの世界市場2018

• 英文タイトル:Global Varicella Attenuated Live Vaccine Sales Market Report 2018

QYResearchが調査・発行した産業分析レポートです。水痘弱毒生ワクチンの世界市場2018 / Global Varicella Attenuated Live Vaccine Sales Market Report 2018 / D109530資料のイメージです。• レポートコード:D109530
• 出版社/出版日:QYResearch / 2018年10月
• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User License¥428,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥856,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、水痘弱毒生ワクチンの世界市場について調査・分析し、水痘弱毒生ワクチンのメーカー別販売量、市場シェア分析、種類別販売分析(一価ワクチン、混合ワクチン)、用途別販売分析(子供用注射、成人用注射)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、水痘弱毒生ワクチン産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・水痘弱毒生ワクチン市場概要
・水痘弱毒生ワクチンのメーカー別販売量・メーカー別シェア
・水痘弱毒生ワクチンの世界市場:種類別販売量(一価ワクチン、混合ワクチン)
・水痘弱毒生ワクチンの世界市場:用途別販売量(子供用注射、成人用注射)
・水痘弱毒生ワクチンの世界市場:地域別販売量・市場シェア
・水痘弱毒生ワクチンの米国市場規模
・水痘弱毒生ワクチンの中国市場規模
・水痘弱毒生ワクチンの欧州市場規模
・水痘弱毒生ワクチンの日本市場規模
・水痘弱毒生ワクチンの東南アジア市場規模
・水痘弱毒生ワクチンのインド市場規模
・水痘弱毒生ワクチンのメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・水痘弱毒生ワクチンのコスト分析・価格動向
・水痘弱毒生ワクチンの産業チェーン(サプライチェーン分析)
・水痘弱毒生ワクチンのマーケティング戦略・販売チャネル、流通業者
・水痘弱毒生ワクチン市場への影響要因分析
・水痘弱毒生ワクチンの世界市場予測
・水痘弱毒生ワクチンの米国市場予測
・水痘弱毒生ワクチンの中国市場予測
・水痘弱毒生ワクチンの欧州市場予測
・水痘弱毒生ワクチンの日本市場予測
・水痘弱毒生ワクチンの東南アジア市場予測
・水痘弱毒生ワクチンのインド市場予測
・水痘弱毒生ワクチンの種類別世界市場予測(一価ワクチン、混合ワクチン)
・水痘弱毒生ワクチンの用途別世界市場予測(子供用注射、成人用注射)
...

This report studies the global Varicella Attenuated Live Vaccine market status and forecast, categorizes the global Varicella Attenuated Live Vaccine market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.
The downstream industries of varicella attenuated live vaccine products are kids and adults. In the recent years, with the recovery of global economic, the development of emerging countries and the rising health concern, the consumption increase of varicella attenuated live vaccine will be obvious. In the foreseeable future, the varicella attenuated live vaccine products will show an optimistic upward trend.
Although sales of varicella attenuated live vaccine products bring a lot of opportunities, the study group recommends the new entrants who just have money but without technical advantage, raw materials advantage and downstream support, do not enter into the Varicella attenuated live vaccine field hastily.
The global Varicella Attenuated Live Vaccine market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major players covered in this report
Merck
GSK
BCHT
Changsheng
Keygen
Green Cross
Biken

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Monovalent Vaccine
Combination Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Kids Injection
Adults Injection

The study objectives of this report are:
To analyze and study the global Varicella Attenuated Live Vaccine sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Varicella Attenuated Live Vaccine players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Varicella Attenuated Live Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Varicella Attenuated Live Vaccine Manufacturers
Varicella Attenuated Live Vaccine Distributors/Traders/Wholesalers
Varicella Attenuated Live Vaccine Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Varicella Attenuated Live Vaccine market, by end-use.
Detailed analysis and profiles of additional market players.

レポート目次

Table of Contents

Global Varicella Attenuated Live Vaccine Sales Market Report 2018
1 Varicella Attenuated Live Vaccine Market Overview
1.1 Product Overview and Scope of Varicella Attenuated Live Vaccine
1.2 Classification of Varicella Attenuated Live Vaccine by Product Category
1.2.1 Global Varicella Attenuated Live Vaccine Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Varicella Attenuated Live Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Monovalent Vaccine
1.2.4 Combination Vaccine
1.3 Global Varicella Attenuated Live Vaccine Market by Application/End Users
1.3.1 Global Varicella Attenuated Live Vaccine Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Kids Injection
1.3.2 Adults Injection
1.4 Global Varicella Attenuated Live Vaccine Market by Region
1.4.1 Global Varicella Attenuated Live Vaccine Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Varicella Attenuated Live Vaccine Status and Prospect (2013-2025)
1.4.3 Europe Varicella Attenuated Live Vaccine Status and Prospect (2013-2025)
1.4.4 China Varicella Attenuated Live Vaccine Status and Prospect (2013-2025)
1.4.5 Japan Varicella Attenuated Live Vaccine Status and Prospect (2013-2025)
1.4.6 Southeast Asia Varicella Attenuated Live Vaccine Status and Prospect (2013-2025)
1.4.7 India Varicella Attenuated Live Vaccine Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Varicella Attenuated Live Vaccine (2013-2025)
1.5.1 Global Varicella Attenuated Live Vaccine Sales and Growth Rate (2013-2025)
1.5.2 Global Varicella Attenuated Live Vaccine Revenue and Growth Rate (2013-2025)

2 Global Varicella Attenuated Live Vaccine Competition by Players/Suppliers, Type and Application
2.1 Global Varicella Attenuated Live Vaccine Market Competition by Players/Suppliers
2.1.1 Global Varicella Attenuated Live Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Varicella Attenuated Live Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Varicella Attenuated Live Vaccine (Volume and Value) by Type
2.2.1 Global Varicella Attenuated Live Vaccine Sales and Market Share by Type (2013-2018)
2.2.2 Global Varicella Attenuated Live Vaccine Revenue and Market Share by Type (2013-2018)
2.3 Global Varicella Attenuated Live Vaccine (Volume and Value) by Region
2.3.1 Global Varicella Attenuated Live Vaccine Sales and Market Share by Region (2013-2018)
2.3.2 Global Varicella Attenuated Live Vaccine Revenue and Market Share by Region (2013-2018)
2.4 Global Varicella Attenuated Live Vaccine (Volume) by Application

3 United States Varicella Attenuated Live Vaccine (Volume, Value and Sales Price)
3.1 United States Varicella Attenuated Live Vaccine Sales and Value (2013-2018)
3.1.1 United States Varicella Attenuated Live Vaccine Sales and Growth Rate (2013-2018)
3.1.2 United States Varicella Attenuated Live Vaccine Revenue and Growth Rate (2013-2018)
3.1.3 United States Varicella Attenuated Live Vaccine Sales Price Trend (2013-2018)
3.2 United States Varicella Attenuated Live Vaccine Sales Volume and Market Share by Players (2013-2018)
3.3 United States Varicella Attenuated Live Vaccine Sales Volume and Market Share by Type (2013-2018)
3.4 United States Varicella Attenuated Live Vaccine Sales Volume and Market Share by Application (2013-2018)

4 Europe Varicella Attenuated Live Vaccine (Volume, Value and Sales Price)
4.1 Europe Varicella Attenuated Live Vaccine Sales and Value (2013-2018)
4.1.1 Europe Varicella Attenuated Live Vaccine Sales and Growth Rate (2013-2018)
4.1.2 Europe Varicella Attenuated Live Vaccine Revenue and Growth Rate (2013-2018)
4.1.3 Europe Varicella Attenuated Live Vaccine Sales Price Trend (2013-2018)
4.2 Europe Varicella Attenuated Live Vaccine Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Varicella Attenuated Live Vaccine Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Varicella Attenuated Live Vaccine Sales Volume and Market Share by Application (2013-2018)

5 China Varicella Attenuated Live Vaccine (Volume, Value and Sales Price)
5.1 China Varicella Attenuated Live Vaccine Sales and Value (2013-2018)
5.1.1 China Varicella Attenuated Live Vaccine Sales and Growth Rate (2013-2018)
5.1.2 China Varicella Attenuated Live Vaccine Revenue and Growth Rate (2013-2018)
5.1.3 China Varicella Attenuated Live Vaccine Sales Price Trend (2013-2018)
5.2 China Varicella Attenuated Live Vaccine Sales Volume and Market Share by Players (2013-2018)
5.3 China Varicella Attenuated Live Vaccine Sales Volume and Market Share by Type (2013-2018)
5.4 China Varicella Attenuated Live Vaccine Sales Volume and Market Share by Application (2013-2018)

6 Japan Varicella Attenuated Live Vaccine (Volume, Value and Sales Price)
6.1 Japan Varicella Attenuated Live Vaccine Sales and Value (2013-2018)
6.1.1 Japan Varicella Attenuated Live Vaccine Sales and Growth Rate (2013-2018)
6.1.2 Japan Varicella Attenuated Live Vaccine Revenue and Growth Rate (2013-2018)
6.1.3 Japan Varicella Attenuated Live Vaccine Sales Price Trend (2013-2018)
6.2 Japan Varicella Attenuated Live Vaccine Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Varicella Attenuated Live Vaccine Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Varicella Attenuated Live Vaccine Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Varicella Attenuated Live Vaccine (Volume, Value and Sales Price)
7.1 Southeast Asia Varicella Attenuated Live Vaccine Sales and Value (2013-2018)
7.1.1 Southeast Asia Varicella Attenuated Live Vaccine Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Varicella Attenuated Live Vaccine Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Varicella Attenuated Live Vaccine Sales Price Trend (2013-2018)
7.2 Southeast Asia Varicella Attenuated Live Vaccine Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Varicella Attenuated Live Vaccine Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Varicella Attenuated Live Vaccine Sales Volume and Market Share by Application (2013-2018)

8 India Varicella Attenuated Live Vaccine (Volume, Value and Sales Price)
8.1 India Varicella Attenuated Live Vaccine Sales and Value (2013-2018)
8.1.1 India Varicella Attenuated Live Vaccine Sales and Growth Rate (2013-2018)
8.1.2 India Varicella Attenuated Live Vaccine Revenue and Growth Rate (2013-2018)
8.1.3 India Varicella Attenuated Live Vaccine Sales Price Trend (2013-2018)
8.2 India Varicella Attenuated Live Vaccine Sales Volume and Market Share by Players (2013-2018)
8.3 India Varicella Attenuated Live Vaccine Sales Volume and Market Share by Type (2013-2018)
8.4 India Varicella Attenuated Live Vaccine Sales Volume and Market Share by Application (2013-2018)

9 Global Varicella Attenuated Live Vaccine Players/Suppliers Profiles and Sales Data
9.1 Merck
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Varicella Attenuated Live Vaccine Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Merck Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 GSK
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Varicella Attenuated Live Vaccine Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 GSK Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 BCHT
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Varicella Attenuated Live Vaccine Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 BCHT Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Changsheng
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Varicella Attenuated Live Vaccine Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Changsheng Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Keygen
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Varicella Attenuated Live Vaccine Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Keygen Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Green Cross
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Varicella Attenuated Live Vaccine Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Green Cross Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Biken
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Varicella Attenuated Live Vaccine Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Biken Varicella Attenuated Live Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview

10 Varicella Attenuated Live Vaccine Maufacturing Cost Analysis
10.1 Varicella Attenuated Live Vaccine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
10.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Varicella Attenuated Live Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Varicella Attenuated Live Vaccine Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Varicella Attenuated Live Vaccine Market Forecast (2018-2025)
14.1 Global Varicella Attenuated Live Vaccine Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Varicella Attenuated Live Vaccine Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Varicella Attenuated Live Vaccine Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Varicella Attenuated Live Vaccine Price and Trend Forecast (2018-2025)
14.2 Global Varicella Attenuated Live Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Varicella Attenuated Live Vaccine Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Varicella Attenuated Live Vaccine Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Varicella Attenuated Live Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Varicella Attenuated Live Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Varicella Attenuated Live Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Varicella Attenuated Live Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Varicella Attenuated Live Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Varicella Attenuated Live Vaccine Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Varicella Attenuated Live Vaccine Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Varicella Attenuated Live Vaccine Sales Forecast by Type (2018-2025)
14.3.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Type (2018-2025)
14.3.3 Global Varicella Attenuated Live Vaccine Price Forecast by Type (2018-2025)
14.4 Global Varicella Attenuated Live Vaccine Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Varicella Attenuated Live Vaccine
Figure Global Varicella Attenuated Live Vaccine Sales Volume Comparison (K Doses) by Type (2013-2025)
Figure Global Varicella Attenuated Live Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Monovalent Vaccine Product Picture
Figure Combination Vaccine Product Picture
Figure Global Varicella Attenuated Live Vaccine Sales Comparison (K Doses) by Application (2013-2025)
Figure Global Sales Market Share of Varicella Attenuated Live Vaccine by Application in 2017
Figure Kids Injection Examples
Table Key Downstream Customer in Kids Injection
Figure Adults Injection Examples
Table Key Downstream Customer in Adults Injection
Figure Global Varicella Attenuated Live Vaccine Market Size (Million USD) by Regions (2013-2025)
Figure United States Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Growth Rate (2013-2025)
Figure Global Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Varicella Attenuated Live Vaccine Sales Volume (K Doses) (2013-2018)
Table Global Varicella Attenuated Live Vaccine Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table Global Varicella Attenuated Live Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Varicella Attenuated Live Vaccine Sales Share by Players/Suppliers
Figure 2017 Varicella Attenuated Live Vaccine Sales Share by Players/Suppliers
Figure Global Varicella Attenuated Live Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Varicella Attenuated Live Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Varicella Attenuated Live Vaccine Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Varicella Attenuated Live Vaccine Revenue Share by Players
Table 2017 Global Varicella Attenuated Live Vaccine Revenue Share by Players
Table Global Varicella Attenuated Live Vaccine Sales (K Doses) and Market Share by Type (2013-2018)
Table Global Varicella Attenuated Live Vaccine Sales Share (K Doses) by Type (2013-2018)
Figure Sales Market Share of Varicella Attenuated Live Vaccine by Type (2013-2018)
Figure Global Varicella Attenuated Live Vaccine Sales Growth Rate by Type (2013-2018)
Table Global Varicella Attenuated Live Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Varicella Attenuated Live Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Varicella Attenuated Live Vaccine by Type (2013-2018)
Figure Global Varicella Attenuated Live Vaccine Revenue Growth Rate by Type (2013-2018)
Table Global Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Market Share by Region (2013-2018)
Table Global Varicella Attenuated Live Vaccine Sales Share by Region (2013-2018)
Figure Sales Market Share of Varicella Attenuated Live Vaccine by Region (2013-2018)
Figure Global Varicella Attenuated Live Vaccine Sales Growth Rate by Region in 2017
Table Global Varicella Attenuated Live Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Varicella Attenuated Live Vaccine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Varicella Attenuated Live Vaccine by Region (2013-2018)
Figure Global Varicella Attenuated Live Vaccine Revenue Growth Rate by Region in 2017
Table Global Varicella Attenuated Live Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Varicella Attenuated Live Vaccine Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Varicella Attenuated Live Vaccine by Region (2013-2018)
Figure Global Varicella Attenuated Live Vaccine Revenue Market Share by Region in 2017
Table Global Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Market Share by Application (2013-2018)
Table Global Varicella Attenuated Live Vaccine Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Varicella Attenuated Live Vaccine by Application (2013-2018)
Figure Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2013-2018)
Figure United States Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure United States Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Varicella Attenuated Live Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table United States Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Players (2013-2018)
Table United States Varicella Attenuated Live Vaccine Sales Volume Market Share by Players (2013-2018)
Figure United States Varicella Attenuated Live Vaccine Sales Volume Market Share by Players in 2017
Table United States Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table United States Varicella Attenuated Live Vaccine Sales Volume Market Share by Type (2013-2018)
Figure United States Varicella Attenuated Live Vaccine Sales Volume Market Share by Type in 2017
Table United States Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Application (2013-2018)
Table United States Varicella Attenuated Live Vaccine Sales Volume Market Share by Application (2013-2018)
Figure United States Varicella Attenuated Live Vaccine Sales Volume Market Share by Application in 2017
Figure Europe Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Europe Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Varicella Attenuated Live Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table Europe Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Players (2013-2018)
Table Europe Varicella Attenuated Live Vaccine Sales Volume Market Share by Players (2013-2018)
Figure Europe Varicella Attenuated Live Vaccine Sales Volume Market Share by Players in 2017
Table Europe Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table Europe Varicella Attenuated Live Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Europe Varicella Attenuated Live Vaccine Sales Volume Market Share by Type in 2017
Table Europe Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Application (2013-2018)
Table Europe Varicella Attenuated Live Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Europe Varicella Attenuated Live Vaccine Sales Volume Market Share by Application in 2017
Figure China Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure China Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Varicella Attenuated Live Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table China Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Players (2013-2018)
Table China Varicella Attenuated Live Vaccine Sales Volume Market Share by Players (2013-2018)
Figure China Varicella Attenuated Live Vaccine Sales Volume Market Share by Players in 2017
Table China Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table China Varicella Attenuated Live Vaccine Sales Volume Market Share by Type (2013-2018)
Figure China Varicella Attenuated Live Vaccine Sales Volume Market Share by Type in 2017
Table China Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Application (2013-2018)
Table China Varicella Attenuated Live Vaccine Sales Volume Market Share by Application (2013-2018)
Figure China Varicella Attenuated Live Vaccine Sales Volume Market Share by Application in 2017
Figure Japan Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Japan Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Varicella Attenuated Live Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table Japan Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Players (2013-2018)
Table Japan Varicella Attenuated Live Vaccine Sales Volume Market Share by Players (2013-2018)
Figure Japan Varicella Attenuated Live Vaccine Sales Volume Market Share by Players in 2017
Table Japan Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table Japan Varicella Attenuated Live Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Japan Varicella Attenuated Live Vaccine Sales Volume Market Share by Type in 2017
Table Japan Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Application (2013-2018)
Table Japan Varicella Attenuated Live Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Japan Varicella Attenuated Live Vaccine Sales Volume Market Share by Application in 2017
Figure Southeast Asia Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure Southeast Asia Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Varicella Attenuated Live Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table Southeast Asia Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Players (2013-2018)
Table Southeast Asia Varicella Attenuated Live Vaccine Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Varicella Attenuated Live Vaccine Sales Volume Market Share by Players in 2017
Table Southeast Asia Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table Southeast Asia Varicella Attenuated Live Vaccine Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Varicella Attenuated Live Vaccine Sales Volume Market Share by Type in 2017
Table Southeast Asia Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Application (2013-2018)
Table Southeast Asia Varicella Attenuated Live Vaccine Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Varicella Attenuated Live Vaccine Sales Volume Market Share by Application in 2017
Figure India Varicella Attenuated Live Vaccine Sales (K Doses) and Growth Rate (2013-2018)
Figure India Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Varicella Attenuated Live Vaccine Sales Price (USD/Dose) Trend (2013-2018)
Table India Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Players (2013-2018)
Table India Varicella Attenuated Live Vaccine Sales Volume Market Share by Players (2013-2018)
Figure India Varicella Attenuated Live Vaccine Sales Volume Market Share by Players in 2017
Table India Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Type (2013-2018)
Table India Varicella Attenuated Live Vaccine Sales Volume Market Share by Type (2013-2018)
Figure India Varicella Attenuated Live Vaccine Sales Volume Market Share by Type in 2017
Table India Varicella Attenuated Live Vaccine Sales Volume (K Doses) by Application (2013-2018)
Table India Varicella Attenuated Live Vaccine Sales Volume Market Share by Application (2013-2018)
Figure India Varicella Attenuated Live Vaccine Sales Volume Market Share by Application in 2017
Table Merck Basic Information List
Table Merck Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck Varicella Attenuated Live Vaccine Sales Growth Rate (2013-2018)
Figure Merck Varicella Attenuated Live Vaccine Sales Global Market Share (2013-2018)
Figure Merck Varicella Attenuated Live Vaccine Revenue Global Market Share (2013-2018)
Table GSK Basic Information List
Table GSK Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GSK Varicella Attenuated Live Vaccine Sales Growth Rate (2013-2018)
Figure GSK Varicella Attenuated Live Vaccine Sales Global Market Share (2013-2018)
Figure GSK Varicella Attenuated Live Vaccine Revenue Global Market Share (2013-2018)
Table BCHT Basic Information List
Table BCHT Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure BCHT Varicella Attenuated Live Vaccine Sales Growth Rate (2013-2018)
Figure BCHT Varicella Attenuated Live Vaccine Sales Global Market Share (2013-2018
Figure BCHT Varicella Attenuated Live Vaccine Revenue Global Market Share (2013-2018)
Table Changsheng Basic Information List
Table Changsheng Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Changsheng Varicella Attenuated Live Vaccine Sales Growth Rate (2013-2018)
Figure Changsheng Varicella Attenuated Live Vaccine Sales Global Market Share (2013-2018)
Figure Changsheng Varicella Attenuated Live Vaccine Revenue Global Market Share (2013-2018)
Table Keygen Basic Information List
Table Keygen Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Keygen Varicella Attenuated Live Vaccine Sales Growth Rate (2013-2018)
Figure Keygen Varicella Attenuated Live Vaccine Sales Global Market Share (2013-2018)
Figure Keygen Varicella Attenuated Live Vaccine Revenue Global Market Share (2013-2018)
Table Green Cross Basic Information List
Table Green Cross Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Green Cross Varicella Attenuated Live Vaccine Sales Growth Rate (2013-2018)
Figure Green Cross Varicella Attenuated Live Vaccine Sales Global Market Share (2013-2018
Figure Green Cross Varicella Attenuated Live Vaccine Revenue Global Market Share (2013-2018)
Table Biken Basic Information List
Table Biken Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Biken Varicella Attenuated Live Vaccine Sales Growth Rate (2013-2018)
Figure Biken Varicella Attenuated Live Vaccine Sales Global Market Share (2013-2018)
Figure Biken Varicella Attenuated Live Vaccine Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Varicella Attenuated Live Vaccine
Figure Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
Figure Varicella Attenuated Live Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Varicella Attenuated Live Vaccine Major Players in 2017
Table Major Buyers of Varicella Attenuated Live Vaccine
Table Distributors/Traders List
Figure Global Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Global Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Varicella Attenuated Live Vaccine Price (USD/Dose) and Trend Forecast (2018-2025)
Table Global Varicella Attenuated Live Vaccine Sales Volume (K Doses) Forecast by Regions (2018-2025)
Figure Global Varicella Attenuated Live Vaccine Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Varicella Attenuated Live Vaccine Sales Volume Market Share Forecast by Regions in 2025
Table Global Varicella Attenuated Live Vaccine Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Varicella Attenuated Live Vaccine Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Varicella Attenuated Live Vaccine Revenue Market Share Forecast by Regions in 2025
Figure United States Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Europe Varicella Attenuated Live Vaccine Revenue and Growth Rate Forecast (2018-2025)
Figure China Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure China Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Japan Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Varicella Attenuated Live Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure India Varicella Attenuated Live Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Varicella Attenuated Live Vaccine Sales (K Doses) Forecast by Type (2018-2025)
Figure Global Varicella Attenuated Live Vaccine Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Varicella Attenuated Live Vaccine Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Varicella Attenuated Live Vaccine Revenue Market Share Forecast by Type (2018-2025)
Table Global Varicella Attenuated Live Vaccine Price (USD/Dose) Forecast by Type (2018-2025)
Table Global Varicella Attenuated Live Vaccine Sales (K Doses) Forecast by Application (2018-2025)
Figure Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources